Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Current Opinion in Neurology
|
February 19, 2026
Decoding Alzheimer's disease through down syndrome: insights from a genetically defined population
Jason K Russell, Zinayida Schlachetzki, Michael S Rafii
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
August 1, 2019
The Role of Estrogen in Brain and Cognitive Aging
Jason K Russell, Carrie K Jones, Paul A Newhouse
JAMA Neurology
|
January 12, 2026
Concordance of Biological and Clinical Staging of Alzheimer Disease Pathology in Down Syndrome
Jason K Russell, Zinayida Schlachetzki, Beau M Ances, et al.
Current Topics in Behavioral Neurosciences
|
November 1, 2024
Cholinergic System Structure and Function Changes in Individuals with Down Syndrome During the Development of Alzheimer's Disease
Jason K Russell, Alexander C Conley, Jo Ellen Wilson, et al.
ACS Chemical Neuroscience
|
January 19, 2023
M<sub>1</sub>/M<sub>4</sub>-Preferring Muscarinic Cholinergic Receptor Agonist Xanomeline Reverses Wake and Arousal Deficits in Nonpathologically Aged Mice
Jason K Russell, Shalonda M Ingram, Laura B Teal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 11, 2026
Relationship of cholinergic basal forebrain atrophy with the time course of Alzheimer's disease pathology and cognitive decline in adults with Down syndrome: a longitudinal cohort study
Jason K Russell, Zinayida Schlachetzki, Alexander C Conley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 26, 2026
Facial feature removal in magnetic resonance imaging scans of adults with Down syndrome: A de-facing methodological study
Jason K Russell, Michael S Rafii, Walter K Kremers, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 2, 2020
Modulation of arousal and sleep/wake architecture by M<sub>1</sub> PAM VU0453595 across young and aged rodents and nonhuman primates
Robert W Gould, Jason K Russell, Michael T Nedelcovych, et al.
Research Square
|
April 16, 2025
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of the Muscarinic M 1 Positive Allosteric Modulator VU0467319 for Alzheimer's disease: A Single Ascending-Dose Study in Healthy Participants
Alexander C Conley, Alexandra P Key, Jennifer U Blackford, et al.
Alzheimer'S Research & Therapy
|
July 2, 2025
Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M<sub>1</sub> positive allosteric modulator VU0467319 for Alzheimer's disease: a single ascending-dose study in healthy participants
Alexander C Conley, Alexandra P Key, Jennifer U Blackford, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Current Opinion in Neurology
|
February 19, 2026
Decoding Alzheimer's disease through down syndrome: insights from a genetically defined population
Jason K Russell, Zinayida Schlachetzki, Michael S Rafii
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
August 1, 2019
The Role of Estrogen in Brain and Cognitive Aging
Jason K Russell, Carrie K Jones, Paul A Newhouse
JAMA Neurology
|
January 12, 2026
Concordance of Biological and Clinical Staging of Alzheimer Disease Pathology in Down Syndrome
Jason K Russell, Zinayida Schlachetzki, Beau M Ances, et al.
Current Topics in Behavioral Neurosciences
|
November 1, 2024
Cholinergic System Structure and Function Changes in Individuals with Down Syndrome During the Development of Alzheimer's Disease
Jason K Russell, Alexander C Conley, Jo Ellen Wilson, et al.
ACS Chemical Neuroscience
|
January 19, 2023
M<sub>1</sub>/M<sub>4</sub>-Preferring Muscarinic Cholinergic Receptor Agonist Xanomeline Reverses Wake and Arousal Deficits in Nonpathologically Aged Mice
Jason K Russell, Shalonda M Ingram, Laura B Teal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 11, 2026
Relationship of cholinergic basal forebrain atrophy with the time course of Alzheimer's disease pathology and cognitive decline in adults with Down syndrome: a longitudinal cohort study
Jason K Russell, Zinayida Schlachetzki, Alexander C Conley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 26, 2026
Facial feature removal in magnetic resonance imaging scans of adults with Down syndrome: A de-facing methodological study
Jason K Russell, Michael S Rafii, Walter K Kremers, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 2, 2020
Modulation of arousal and sleep/wake architecture by M<sub>1</sub> PAM VU0453595 across young and aged rodents and nonhuman primates
Robert W Gould, Jason K Russell, Michael T Nedelcovych, et al.
Research Square
|
April 16, 2025
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of the Muscarinic M 1 Positive Allosteric Modulator VU0467319 for Alzheimer's disease: A Single Ascending-Dose Study in Healthy Participants
Alexander C Conley, Alexandra P Key, Jennifer U Blackford, et al.
Alzheimer'S Research & Therapy
|
July 2, 2025
Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M<sub>1</sub> positive allosteric modulator VU0467319 for Alzheimer's disease: a single ascending-dose study in healthy participants
Alexander C Conley, Alexandra P Key, Jennifer U Blackford, et al.
Page
of 2